Quick Answer
Onconetix, Inc. reported Operating Income Loss of -$17.86 million for the year ending 2025.
- Onconetix, Inc. showed an increase of +68.4% in Operating Income Loss from 2024 to 2025.
- This data is from Onconetix, Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), Onconetix, Inc.'s Operating Income Loss has declined by 422.5%.
- Historical annual values: Fiscal year 2025: -$17.86 million | Fiscal year 2024: -$56.49 million | Fiscal year 2023: -$36.03 million | Fiscal year 2022: -$13.48 million | Fiscal year 2021: -$3.42 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: